Smartlab Europe

RAUMEDIC and Sartorius Stedim Biotech Sign Partnership Agreement

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

ICON Advarra Partnership Builds Research-Ready Trial Model

ICON, a world-leading clinical research organisation, has formalised a...

Novartis China Investment Expands R&D and Manufacturing

Novartis is stepping up its presence in China with...

UK Backs Respiratory Transformation Partnership with £10m

The NHS has partnered with leading pharmaceutical companies to...
- Advertisement -

Sartorius Stedim Biotech (SSB), an international leading pharma and biotech supplier, and RAUMEDIC, a leading worldwide OEM manufacturer of medical- and pharmaceutical-grade polymer components and systems, announced the signing of a global partnership agreement.

This covers arrangements concerning the mutual development of innovative fluid systems and marketing of single-use tubing, which RAUMEDIC produces for and will supply to Sartorius Stedim Biotech on a long-term basis.

Sartorius Stedim Biotech will be combining its designing, manufacturing and validation expertise in single-use systems for biopharmaceutical applications with RAUMEDIC proficiency in the development and manufacture of tubing for medical and biopharmaceutical use. The alliance will provide innovative, high-quality and reliable fluid handling systems to biopharmaceutical manufacturers. Through this strategic partnership with RAUMEDIC, Sartorius Stedim Biotech will substantially expand its product and service portfolio in the area of liquid transfer technologies.

Latest stories

Related stories

ICON Advarra Partnership Builds Research-Ready Trial Model

ICON, a world-leading clinical research organisation, has formalised a...

Novartis China Investment Expands R&D and Manufacturing

Novartis is stepping up its presence in China with...

UK Backs Respiratory Transformation Partnership with £10m

The NHS has partnered with leading pharmaceutical companies to...

The Invisible Costs Undermining Pharma Profit Margins and the Digital Fixes Gaining Traction

Pharmaceutical companies spend extraordinary amounts optimising what they can...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »